Monday, November 26, 2012

• Interim Results of the Phase 2b/3 GALAXY Trial to be Presented at the Fifth Asia Pacific Lung Cancer ConferenceBusiness Wire (Mon, Nov 26)

Wednesday, November 14, 2012

• 5 Healthcare Companies With Significant Recent Insider Buying (Part IV)at Seeking Alpha (Wed, Nov 14)

Friday, November 9, 2012

• Synta to Present at the Lazard Capital Markets 9th Annual Healthcare ConferenceBusiness Wire (Fri, Nov 9)

Wednesday, November 7, 2012

• Interim Results of the Phase 2b GALAXY Trial to be Presented at the Chemotherapy Foundation SymposiumBusiness Wire (Wed, Nov 7)

Tuesday, November 6, 2012

• Synta Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Tue, Nov 6)
• Synta Provides Clinical Update and Reports Third Quarter 2012 Financial ResultsBusiness Wire (Tue, Nov 6)
• SYNTA PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Nov 6)

Monday, November 5, 2012

• Investments In The Fight Against Cancer: The Analysts' Choicesat Seeking Alpha (Mon, Nov 5)

Monday, October 8, 2012

• Winners Of ESMO 2012at Seeking Alpha (Mon, Oct 8)

Tuesday, October 2, 2012

• Ocwen Financial Teams Up With IBM and 4 Stocks Riding 52-Week Highsat Wall St. Cheat Sheet (Tue, Oct 2)

Monday, October 1, 2012

• 2-Star Stocks Poised to Plunge: Synta Pharmaceuticals?at Motley Fool (Mon, Oct 1)
• Goldman Sachs Upbeat About Commodities and 4 Hot Stocks Buzzing on The Streetat Wall St. Cheat Sheet (Mon, Oct 1)
• SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Oct 1)
• Another Change in CharacterTheStreet (Mon, Oct 1)

Friday, September 21, 2012

• 3 Pharma Stocks With Upcoming Catalystsat Motley Fool (Fri, Sep 21)
• [video] The Next Big Thing in Biotech: Cancer Drugsat TheStreet (Fri, Sep 21)

Thursday, September 20, 2012

• 5 Stocks Under $10 Set to Soarat TheStreet (Thu, Sep 20)

Wednesday, September 19, 2012

• U.S. Biotech Valuations Appear Attractive Despite Earlier Run: a Wall Street Transcript Interview with Jim Birchenough, Managing Director at BMO Capital Markets and Senior Biotechnology AnalystWall Street Transcript (Wed, Sep 19)
• New Legislation Passed to Help Speed Up FDA Review ProcessMarketwired (Wed, Sep 19)

Tuesday, September 18, 2012

• 5 Highly Shorted Small-Caps With Strong Insider And Institutional Buyingat Seeking Alpha (Tue, Sep 18)

Thursday, September 13, 2012

• 5 Stocks Under $10 Soaring Higherat TheStreet (Thu, Sep 13)

Thursday, September 6, 2012

• Biotech Merger and Acquisition Activity at a Four-Year High as Major Pharmaceuticals Look to Replace Lost RevenuesMarketwired (Thu, Sep 6)

Thursday, August 30, 2012

• Citrix Systems INITIATED at Neutral and 3 Initiated Shares to Watchat Wall St. Cheat Sheet (Thu, Aug 30)

Thursday, August 2, 2012

• SYNTA PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Aug 2)

Tuesday, July 31, 2012

• The Best And Worst Performing Biotech Stocks In Julyat Forbes (Tue, Jul 31)

Add SNTA News to My Yahoo!